OneMedNet Seeks Shareholder Nod for Reverse Split and Equity Plan Boost to Fend Off Nasdaq Delisting
ONMD sits 41% above its 52-week low of $0.44.
Summary
OneMedNet's preliminary proxy seeks approval for a reverse stock split (up to 1-for-20) to avoid Nasdaq delisting and a 1-million-share increase to its equity plan to retain talent amid financial distress.
Key Events · Corporate Governance and Compliance · ONMD
-
Reverse Stock Split Proposed
To lift the stock price above Nasdaq's $1.00 minimum bid requirement, the board seeks authority to implement a reverse stock split at a ratio between 1-for-5 and 1-for-20. The company has until October 12, 2026 to regain compliance.
-
Equity Plan Share Increase
A proposal would add 1,000,000 shares to the 2022 Equity Incentive Plan, increasing the reserve to 3,357,223 shares. The plan is the sole source of equity awards for employees and directors.
-
Nasdaq Delisting Risk
A deficiency notice was received on April 14, 2026 for failing to maintain a $1.00 minimum bid price. Failure to approve the reverse split could lead to delisting, severely impacting liquidity and capital-raising ability.
-
Annual Meeting Set for September 18
Shareholders will vote on the proposals at a virtual annual meeting on September 18, 2026. The record date is in August 2026.
Analysis · ONMD · Industrial Applications And Services
Management is asking shareholders to greenlight a reverse stock split of up to 1-for-20 and a 1-million-share increase to its equity incentive plan. The reverse split is critical to regain compliance with Nasdaq's $1.00 minimum bid price requirement — the company has until October 12, 2026 to fix the deficiency. Without it, delisting to the OTC markets would severely impair liquidity and fundraising ability. The equity plan expansion, while dilutive, is needed to retain and incentivize key talent as the company navigates a going concern warning and a recent $25 million dilutive equity line. Both proposals are defensive measures aimed at survival and maintaining exchange listing.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.80%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ONMD was trading at $0.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.6M. The 52-week trading range was $0.44 to $4.22. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.